Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Economic Growth, Improving Medical Infrastructure Backing E7 Pharma Markets
Jun 20, 2008
A new market research report, “Emerging Pharmaceutical Markets Globally”, recently released by RNCOS says that the pharmaceutical markets in E7 countries are anticipated to grow at a CAGR of 11.5% from 2008 to 2012. This growth rate is more than double of that in G7 markets.
The report identifies that strong economic growth in E7 countries is one of the main reasons driving growth in their pharmaceutical markets. The total disposable income of the E7 countries is anticipated to grow two-fold in 2012 against US$ 4.4 Trillion in 2007, which will increase the expenditure on healthcare and drugs in the region.
Furthermore, the medical infrastructure has developed tremendously in the E7 countries in the last decade, says the report. As a result, a large number of clinics and hospitals have opened in these countries. With opening of new clinics and hospitals, patients are increasingly taking professional advice from physicians instead of following self-medication and conventional therapies. As the sales of pharmaceutical sector are directly linked to physician visits, a rise in physician visits has augmented the sales.
Besides, the report says that an improvement in the medical infrastructure has directly impacted the smaller towns and villages where majority of E7 countries’ population resides. The volume of retail pharmaceutical stores in small towns and villages has substantially expanded in the last decade, providing quality and affordable drugs in these areas.
“Emerging Pharmaceutical Markets Globally” is a comprehensive report providing data on emerging pharmaceutical markets worldwide. It highlights the difference between developed and emerging markets in terms of traditional therapies, health and insurance scenario, and intellectual property, giving critical information to pharmaceutical companies and investors planning to enter these markets to help them make strategies according to the E7 markets. The report also gives forecast on generic drugs and domestic pharmaceutical markets by region and country.
For more information visit: http://www.rncos.com/Report/IM081.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Novel Parkinson Disease Drugs Aid in Reducing “Off” Time in Patients
- Nanotechnology Mediated Targeted Drug Delivery for Cancer Treatment: Gaining Momentum
- Stem Cell Therapy – A Breakthrough in Parkinson’s Disease Treatment
- Lentiviral Vectors: Emerging as a Promising Tool for T-Cell Immunotherapy
- Nanosized Drug Delivery Systems Revolutionizing Entire Drug Therapy Strategy
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact